✦ LIBER ✦

Candesartan Cilexetil/Hydrochlorothiazide Treatment in High-Risk Patients with Type 2 Diabetes Mellitus and Microalbuminuria

✍ Scribed by Prof. Dr Reinhard Ketelhut, Peter Bramlage

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

H37 Candesartan cilexetil, a novel angio

✍ C. Forsblom; P. Trenkwalder; K. Dahl; H. Mulder 📂 Article 📅 1997 🏛 Nature Publishing Group 🌐 English ⚖ 274 KB

Combination therapy of trandolapril and

✍ T. Nakamura; C. Ushiyama; S. Osada; Y. Takahashi; N. Shimada; I. Ebihara; H. Koi 📂 Article 📅 2002 🏛 Springer 🌐 English ⚖ 122 KB

Insulin treatment improves microalbuminu

✍ Dr T. Lindström; A. G. Olsson; H. Von Schenck; L. Wallentin; H. J. Arnqvist 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 761 KB

Microalbuminuria Cardiovascular Risk Fac

✍ A.M. Hodge; G.K. Dowse; P.Z. Zimmet 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 864 KB

Microalbuminuria, cardiovascular autonom

✍ Naohiko Takahashi; Futoshi Anan; Mikiko Nakagawa; Kunio Yufu; Tatsuhiko Ooie; To 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 113 KB

Dalcetrapib in High-Risk Patients with T

✍ Michael H. Davidson; Anton F.H. Stalenhoef; Jennifer G. Robinson; Regina Duttlin 📂 Article 📅 2009 🏛 Elsevier 🌐 English ⚖ 37 KB